Effects of oral, continuous and transdermal cyclic 17-? estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women
dc.authorwosid | SAYIN, N. CENK/A-5801-2018 | |
dc.contributor.author | Kaplan, PB | |
dc.contributor.author | Gücer, F | |
dc.contributor.author | Sayin, NC | |
dc.contributor.author | Yüce, MA | |
dc.contributor.author | Yardim, T | |
dc.date.accessioned | 2024-06-12T11:12:39Z | |
dc.date.available | 2024-06-12T11:12:39Z | |
dc.date.issued | 2002 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: To evaluate the affects of an oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate combination on platelet aggregation in postmenopausal women. STUDY DESIGN: Fifty postmenopausal women were randomly assigned to receive 17-beta estradiol and norethindrone acetate either orally continuously or transdermally cyclically and sequentially. Platelet counts and maximum platelet aggregation rates were measured before and after three months treatment. RESULTS: At three months there were no significant changes in platelet counts or in adenosine diphosphate-induced or epinephrine-induced platelet aggregation rates in either treatment group. CONCLUSION: Hormone replacement treatment with a 17-beta estradiol and norethindrone. acetate combination either orally continuously or transdermally cyclically and sequentially does not affect platelet aggregation in postmenopausal women. | en_US |
dc.identifier.endpage | 655 | en_US |
dc.identifier.issn | 0024-7758 | |
dc.identifier.issn | 1943-3565 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 12216432 | en_US |
dc.identifier.startpage | 651 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/23259 | |
dc.identifier.volume | 47 | en_US |
dc.identifier.wos | WOS:000177657900010 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sci Printers & Publ Inc | en_US |
dc.relation.ispartof | Journal Of Reproductive Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Postmenopausal Hormone Replacement | en_US |
dc.subject | Therapy | en_US |
dc.subject | Postmenopause | en_US |
dc.subject | Platelet Aggregation | en_US |
dc.subject | Cardiovascular Risk-Factors | en_US |
dc.subject | Venous Thromboembolism | en_US |
dc.subject | Estrogens | en_US |
dc.subject | Heart | en_US |
dc.subject | Menopause | en_US |
dc.subject | Hormones | en_US |
dc.subject | Disease | en_US |
dc.subject | Users | en_US |
dc.title | Effects of oral, continuous and transdermal cyclic 17-? estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women | en_US |
dc.type | Article | en_US |